Add time:09/02/2019 Source:sciencedirect.com
An in depth study on photodegradation of Barnidipine (cas 104757-53-1), a new 1,4-dihydropyridine antihypertensive drug, was performed by exposing the drug to natural and stressing light irradiation. A different degradation process and distribution of photoproducts under different light sources and irradiation power were demonstrated. Degradation kinetics, reactive excited states involved, transient species and photoproducts generated were investigated. Exposure of barnidipine to forced irradiation caused a complex degradation pathway. Kinetics of this process was studied by HPLC and spectrophotometry, demonstrating the formation of several by-products. In contrast, the drug, under direct or indirect sunlight, underwent oxidation generating the pyridine derivative as the main photodegradation product, according to most of the drug congeners. HPLC and derivative spectrophotometric methods were defined for the simultaneous assay of the drug and its pyridinic by-product, useful as a routine control method of the drug formulations.
We also recommend Trading Suppliers and Manufacturers of Barnidipine (cas 104757-53-1). Pls Click Website Link as below: cas 104757-53-1 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View